Advertisement

Picture Berlin Partner Berlin-Brandenburg Healthcare Industries Cluster 650x80px

Deals > All

Find below collaborations, license and distribution agreements, grants, investments and loan agreements in Austria, Germany and Switzerland or involving organisations from these countries.

Total search results: 3067 | Ordered by Date (descending)
next pagenext page 1 2 3 ... 21 22 23 ... 29 30 31  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Amal Therapeutics–SEVERAL: investment, 201709 financing round Series B first closing €8m co-led by BIVF + BioMedPartners + Helsinn 2017-09-05
Amal Therapeutics–VI Partners: investment, 201709 financing round Series B first closing totalling €8m incl co-investor VI Partners 2017-09-05
Immunic–SEVERAL: investment, 201709 financing round Series A extension €10m led by LSP bringing total Series A to €31.7m 2017-09-05
Metabolomic Discoveries–Metabolon: investment, 201709 acquisition €na of Metabolomic Discoveries GmbH by Metabolon Inc 2017-09-05
Pharnext–MC Services: public relations, 201709 service existent investor relations Europe by MC Services 2017-09-05
Boehringer–Allcyte: drug discovery, 201709– collab using Pharmacoscopy ex vivo drug response profiling platform for BI oncology candidates 2017-09-04
Amcure–Germany (govt): grant, 201708 BMBF research grant €1.75m to advance clinical lead candidate AMC303 2017-08-31
Angiex–Merck (DE): drug development services, 201708– supply BioReliance End-to-End Solutions for developm of ADC therapy of Angiex Inc 2017-08-29
Apeiron–EU (govt): credit, 201708– EIB EFSI loan €25m to support developm of cancer drugs 2017-08-28
Kite Pharma–Gilead: investment, 201708–201710 acquisition $11.9b cash tender offer $180/share 2017-08-28
Natrix Separations–Merck (DE): investment, 201708– acquisition €na of Natrix Separations by Merck ANNOUNCED 2017-08-28
Aurealis Pharma–SEVERAL: investment, 201708 financing round Series A CHF5.6m from private investors + Finnvera + Tekes 2017-08-25
Novartis–Xoma: IL-1 beta antibodies, 201708– license $26m upfront + $5m investment + milestones + royalties ww rights to gevokizumab + IL-beta Ab IP 2017-08-25
Labfolder–Germany (govt): business development, 201708– supply service support in US with German Accelerator Life Sciences programme 2017-08-24
Macrophage Pharma–Merck (DE): investment, 201708 financing round Series A extension with new investor Merk Ventures 2017-08-23
Batavia–UGA Biopharma: cell line development, –201708 collab devleopm of 2 enzmye expressing monoclonal cell lines for biopharma production 2017-08-22
CRISPR Therapeutics–Partners HealthCare: cell therapy, 201708– collab research + license option 2y w MGHCC develop cancer T cell therapies w CRISPR 2017-08-22
Lilly–Topas Therapeutics: immuno modulatory compounds, 201708– collab €na multi-y research + option agreem 2017-08-22
Micro-Sphere–Ramarketing: public relations, 201708– service by Ramarketing 2017-08-22
AstraZeneca–Ethris: mRNA-based therapeutics, 201708– collab research 5y w €25m upfront + funding + milestones using SNIM®RNA technology 2017-08-21
Ethris–MacDougall Biomedical Communications: public relations, 201708 service existent by MacDougall 2017-08-21
Rodos BioTarget–SEVERAL: investment, 201708 capital increase €800k via crowdfunding platform Aescuvest 2017-08-18
Biotecon–Bruker: mass spectrometer, 201708– distribution OEM of MALDI Biotyper platforms for food analysis in DACH region + Eastern Europe 2017-08-16
Monsanto–ToolGen: CRISPR technology, 201708– license ww €na for use of ToolGen’s CRISPR technology platform in agricultural products 2017-08-16
Roche–Mimetas: organ-on-a-chip technology, –201708 collab developm gut model on-a-chip using OrganoPlate platform 2017-08-16
Purdue Pharma–CellAct: cancer drug, 201708– acquisition ww developm + commerc rights to CAP7.1 by Mundipharma from CellAct 2017-08-14
Roivant–SEVERAL: investment, 201708 financing round $1.1b led by SoftBank Vision Fund + incl Dexxon investor group 2017-08-09
Roivant–SoftBank: investment, 201708 financing round totalling $1.1b incl new + lead investor SoftBank Vision Fund 2017-08-09
Diagnosticum (HU)–Bruker: food analysis, 201708 collab to form Hungarian Wine Consortium using NMR FoodScreener for wine analysis 2017-08-08
IFM Therapeutics–BMS: investment, 201708– acquisition two cancer assets for $300m upfront + up to $2.02b milestones 2017-08-03
Bruker–OTHER: immunoassay technology, 201708 acquisition €na of portable chip-based ELISA platform by Bruker 2017-08-02
Homology Medicines–HBM: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor HBM Healthcare Investments 2017-08-01
Homology Medicines–Novartis: investment, 201708 financing round Series B totalling $83.5m incl new + co-investor Novartis 2017-08-01
Homology Medicines–SEVERAL: investment, 201708 financing round Series B $83.5m led by Deerfield Management 2017-08-01
Lyocontract–Lyomark Pharma: investment, 201708 acquisition of majority share in Lyocontract GmbH by Lyomark Pharma GmbH 2017-08-01
Aptuit–Evotec: investment, 201707–201708 acquisition $300m in cash of Aptuit from Welsh, Carson, Anderson & Stowe 2017-07-30
Evoxx Technologies–Advanced Enzyme Technologies: investment, 201707– acquisition 100% by Advanced Enzymes ANNOUNCED 2017-07-28
Protembis–Germany (govt): grant, 201507 BMBF grant 7-digit € for Protembis in collab with RWTH Aachen 2017-07-28
Evosciences–Danaher: mass spectrometer, 201707– distribution of Sciex MS systems with flexible finacing packages via Evosciences in Europe 2017-07-27
Genkyotex–Alize RP: public relations, 201707 service existent media relations by Alize RP 2017-07-27
Genkyotex–LifeSci: public relations, 201707 service existent in US by LifeSci Advisors 2017-07-27
Genkyotex–NewCap: public relations, 201707 service existent IR by NewCap 2017-07-27
JnJ–Proteros: drug discovery services, 201707– collab €na lead discovery small molecule cancer drugs using NEAT for Jannsen Biotech 2017-07-27
stimOS–Baden-Württemberg (govt): investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–High-Tech Gründerfonds: investment, 201707 seed financing round totalling €720k from HTGF + MBG Baden-Württemberg 2017-07-27
stimOS–SEVERAL: investment, 201707 seed financing round €720k from HTGF + MBG Baden-Württemberg 2017-07-27
Storm Therapeutics–Evotec: drug discovery services, 201707– supply service expansion €na HTS + structural biology plus chemistry + new targets 2017-07-27
Jazz Pharmaceuticals–XL-protein: PASylation technology, 201707– license $2m upfront + funding + milestones + royalties to develop asparaginase drugs 2017-07-26
Micro-Macinazione–Lonza: investment, 201707 acquisition €na of Micro-Macinazione from Cross Equity Fund 2017-07-26
DiaSorin–Siemens: ELISA immunoassays, 201707– acquisition up to €47.5m of Siemens ELISA Dx portfolio/assets without employees + mftg capacity 2017-07-25
Protembis–Germany (govt): business development, 201707– supply service support in US with German Accelerator Life Sciences programme 2017-07-25
Bayer–Evotec: drug discovery services, 201707–201812 collab extension endometriosis alliance after reaching milestone of start of phase 1 2017-07-24
Boehringer–Philogen: drug discovery services, 201707– collab €na discovery + optimisation of small molecule drugs using ESAC technology 2017-07-20
Spindiag–OTHER: investment, 201707 seed financing round €1.6m from three private investors 2017-07-20
Humabs BioMed–MC Services: public relations, 201707 service existent by MC Services AG 2017-07-18
Shire–Novimmune: therapeutic antibodies, 201707– license ww excl €na to bispecific antibody for hemophilia A 2017-07-18
TomTec Imaging–Philips: investment, 201707– acquisition €na of TomTec Imaging Systems GmbH by Philips ANNOUNCED 2017-07-18
BASF–Kaiima: plant biotechnology, 201707– collab research multi-year using EP technology to discover herbicide resistent traits 2017-07-17
Maruho–4SC: Kv1.3 inhibitors, 201707–202009 license ww excl for up to total €208m upfront + milestones plus royalties TERMINATED 9/20 2017-07-15
Diagenode–PreOmics: proteomic sample preparation, –201707 collab developm combi of Bioruptor + iST Kit to clean peptides for MS 2017-07-14
NofaGroup–Cotecna: investment, 201707 acquisition of NofaGroup by Cotecna Inspection SA 2017-07-13
ABF–Genedata: bioinformatics, 201707– supply expansion use of Genedata Selector by AB Enzymes for decision support 2017-07-11
Blueprint Genetics–Creathor Ventures: investment, 201707 financing round totalling up to €14m incl new + co-lead investor Creathor Venture 2017-07-11
Blueprint Genetics–Inventure: investment, 201707 financing round totalling up to €14m incl existing + co-investor Inventure 2017-07-11
Blueprint Genetics–MedTech Innovation Partners: investment, 201707 financing round totalling up to €14m incl new + co-lead investor MTIP 2017-07-11
Blueprint Genetics–Pontos Group: investment, 201707 financing round totalling up to €14m incl existing + co-investor Pontos Group 2017-07-11
Blueprint Genetics–SEVERAL: investment, 201707 financing round up to €14m led by Creathor Venture + MTIP + incl Inventure + Pontos Group 2017-07-11
Nestlé–Enterome: diagnostics, 201707– collab establishm of 50/50 jv MDP to develop microbiome-based diagnostics except for immuno-oncology 2017-07-11
CRISPR Therapeutics–Neon Therapeutics: T cell therapy, 201707– collab combi of proprietary technologies to develop T cell therapies 2017-07-10
Endress+Hauser–GUS Group: investment, 201707 acquisition of AJ Blomesystem GmbH by GUS Group 2017-07-01
Evotec–Hamburg (govt): grant, 201707– 201906 RnD grant from IFB Hamburg to develop AB-based cancer therapies with UKE 2017-07-01
Global Bioenergies–SEVERAL: investment, 201706 capital increase €10.24m via private placement of 640k new shares at €16/share 2017-06-30
mySugr–Roche: investment, 201706 acquisition of remaining shares by Roche 2017-06-30
Evotec–Censo Biotechnologies: stem cell technology, 201706–201905 strategic collab €na with Censo supplying iPS cell lines to Evotec 2017-06-28
Indi Molecular–Merck (DE): investment, 201706 financing round Series A totalling $11.5m led by Merck Ventures + Legend Capital 2017-06-28
Indi Molecular–SEVERAL: investment, 201706 financing round Series A $11.5m led by Merck Ventures + Legend Capital 2017-06-28
BioGeneration Ventures–EU (govt): investment, 201706 investment by EIF + other new investors bringing total capital of BGV III to €66m 2017-06-27
BioGeneration Ventures–SEVERAL: investment, 201706 investm by EIF + other new investors bringing total capital of BGV III to €66m with max target €75m 2017-06-27
Catalym–BioGeneration Ventures: investment, 201706 CatalYm GmbH is existent investment of BGV III fund 2017-06-27
Sensovation–Miltenyi Biotec: investment, 201706 acquisition by Milteny from HeidelbergCapital + KfW/tbg 2017-06-27
Takeda–JSR Corp: cell line development, 201706– commercial license to use Selexis’ SUREtechnology for developm of fusion proteins 2017-06-27
Ottobock–EQT: investment, 201706 EQT VII fund to acquire 20% stake from Otto Bock HealthCare GmbH valuing Ottobock at €3.15b 2017-06-24
DiaSorin–Qiagen: in vitro diagnostics, 201706– collab to adopt select Qiagen assays for use on Liaison platform 2017-06-22
Repare Therapeutics–SEVERAL: investment, 201706 financing round Series A $68m co-led by Versant Ventures + MPM Capital 2017-06-22
AlsaChim–Shimadzu: investment, 201706 acquisition €na of 100% of AlsaChim by Shimadzu Europe 2017-06-21
FB Health–Invent Farma/Neuraxpharm: investment, 201706 acquisition €na of FB Health by Invent Farma/Neuraxpharm (formed 8/16 by Apax Partners) 2017-06-21
Debiopharm–Almac: kinase inhibitor, 201706– license ww excl to Wee-1 kinase inhibitor programme of Almac Discovery 2017-06-20
Facio Therapies–Evotec: investment, 201706c financing round totalling €4.8m incl strategic investment by Evotec 2017-06-20
Facio Therapies–SEVERAL: investment, 201706c financing round €4.8m incl Evotec + members of intl FSHD community 2017-06-20
Idorsia–JnJ: investment, 201706 acquisition of 9.9% share in Idorsia by Cilag Holding AG via conversion of CFH135.4m convertable loan 2017-06-20
Euroimmun–PerkinElmer: investment, 201706–201712 acquisition $1.3b in cash 2017-06-19
Hopp Group–CRS Clinical Research Services: investment, 201706 management buy-out of CRS from LTS via holding Apleonex AG 2017-06-19
Takeda–Wilex: antibody-drug conjugates, 201706– collab developm of ADCs using ATACs for up to 3 targets Heidelberg Pharma + Millennium 2017-06-19
TxCell–Miltenyi Biotec: lentiviral vector, 201706– supply of lentiviral vector for TxCell’s CAR-Tregs targeting transplant rejection by Lentigen 2017-06-19
Broughton Laboratories–Thermo Fisher: LC system, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
Broughton Laboratories–Thermo Fisher: mass spectrometer, 201706 supply two Vanquish Flex UPLC systems coupled to TSQ Endura TQ-MS detectors 2017-06-16
GreenBone–Helsinn: investment, 201706 2nd financing round incl €2m from lead investor Helsinn Investment Fund 2017-06-16
GreenBone–SEVERAL: investment, 201706 2nd financing round incl lead investor Helsinn Investment Fund 2017-06-16
Idorsia–OTHER: investment, 201706 listing at SIX Swiss Exchange as part of acquisition of Actelion by JnJ and spin-off of Idorsia 2017-06-16
Medicxi Ventures–Alphabet: investment, 201706 closing totalling $300m of MG1 fund incl cornerstone investors EIF + Novartis + Verily 2017-06-15
next pagenext page 1 2 3 ... 21 22 23 ... 29 30 31  next pagenext page



Advertisement

Picture EBD Group Connector Personal Networking in Life Sciences 650x80

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture Berlin Partner Network in German Capital Region 650x80px

» top